Bharat Biotech Mulls IPO To Raise Over $500 Million
New Delhi: The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over ...
New Delhi: The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over ...